Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Scholar Rock Holding Corp SRRK

Healthcare Biotechnology
Scholar Rock Holding Corporation is a biopharmaceutical company. The Company is focused on the discovery, development and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its transforming growth factor beta (TGFb) superfamily biology, its novel molecular mechanisms of growth factor activation enabled the Company... see more

Recent & Breaking News (NDAQ:SRRK)

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire December 15, 2023

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire November 17, 2023

Scholar Rock Reports Third Quarter 2023 Financial Results and Highlights Business Progress

Business Wire November 7, 2023

Scholar Rock Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients and Supporting SRK-181 Continued Tolerability

Business Wire November 3, 2023

Scholar Rock to Participate in Upcoming Investor Conferences

Business Wire November 2, 2023

Scholar Rock to Present Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 38th Annual Meeting

Business Wire October 19, 2023

Scholar Rock Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares

Business Wire October 16, 2023

Scholar Rock Announces Pricing of Upsized Public Offering of Common Stock

Business Wire October 11, 2023

Scholar Rock Announces Proposed Public Offering of Common Stock

Business Wire October 11, 2023

Scholar Rock to Advance Antimyostatin Program to Develop Novel Therapies for Cardiometabolic Disorders

Business Wire October 11, 2023

Scholar Rock Announces Completion of Enrollment for the Phase 3 SAPPHIRE Trial

Business Wire September 19, 2023

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire September 15, 2023

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire August 18, 2023

Scholar Rock Reports Second Quarter 2023 Financial Results and Highlights Business Progress

Business Wire August 9, 2023

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire July 13, 2023

New 36-Month Apitegromab Extension Data Reinforce Long-Term Substantial and Sustained Improvement of Motor Function in Phase 2 TOPAZ Trial Patients with Nonambulatory Spinal Muscular Atrophy

Business Wire June 30, 2023

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire June 15, 2023

Scholar Rock to Present at the Jefferies Healthcare Conference

Business Wire June 1, 2023

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire May 10, 2023

Scholar Rock Reports First Quarter 2023 Financial Results and Highlights Business Progress

Business Wire May 9, 2023